These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 21961327)
1. [Current aspects of pathogenetic therapy in tuberculosis]. Balasaniants GS; Sukhanov DS Ter Arkh; 2011; 83(8):21-4. PubMed ID: 21961327 [TBL] [Abstract][Full Text] [Related]
2. [Effect of antioxidants on lipid peroxidation and on liver function in patients with pulmonary tuberculosis]. Skakun NL; Blikhar EI Farmakol Toksikol; 1986; 49(5):112-4. PubMed ID: 3770163 [TBL] [Abstract][Full Text] [Related]
3. [Pathogenetic therapy in pulmonary tuberculosis]. Starostenko EV Probl Tuberk; 1989; (5):22-6. PubMed ID: 2748555 [TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy of destructive pulmonary tuberculosis with antioxidants and antihypoxic agents]. Savula MM; Kravchenko NS; Poznanskiĭ AI Probl Tuberk; 1993; (5):18-20. PubMed ID: 8295877 [TBL] [Abstract][Full Text] [Related]
5. [Adverse effects of multi-drug therapy in patients with tuberculosis and ways of their correction]. Gel'berg IS; Vol'f SB; Vrublevskaia NI; Pigalkova EN; Krotkova EN; Shevchuk DV; Avlasenko VS Probl Tuberk; 2002; (4):12-6. PubMed ID: 12125243 [TBL] [Abstract][Full Text] [Related]
6. [The use of antioxidants and antihypoxants in tuberculosis (a review of the literature)]. Skakun NP Vrach Delo; 1991 Mar; (3):52-6. PubMed ID: 2042350 [No Abstract] [Full Text] [Related]
8. [Antioxidant treatment of pulmonary tuberculosis in patients with chronic alcoholism]. Burnusus ZI Probl Tuberk; 1992; (5-6):28-30. PubMed ID: 1409509 [TBL] [Abstract][Full Text] [Related]
9. [Remaxol hepatoprotective therapy of patients with tuberculosis and HIV infection in day unit of tuberculosis dispensary]. Shevyreva EV; Ivanov AK; Sukhanov DS; Murzina AA Antibiot Khimioter; 2012; 57(7-8):31-7. PubMed ID: 23350192 [TBL] [Abstract][Full Text] [Related]
10. [Some current problems in initial chemotherapy of pulmonary tuberculosis]. Ionesco C; Pirozynski M Rev Med Chir Soc Med Nat Iasi; 1971; 75(4):883-8. PubMed ID: 5164529 [No Abstract] [Full Text] [Related]
11. [Antioxidant effectiveness in preventing and eliminating the side effects of antibacterial preparations in pulmonary tuberculosis patients]. Starostenko EV; Andrzheiuk NI; Salpagarov AM Probl Tuberk; 1987; (10):34-7. PubMed ID: 3422950 [No Abstract] [Full Text] [Related]
12. [Thiopoeitins in the treatment of tuberculosis]. Sinitsyn MV; Bogadel'nikova IV; Sokolova GB Probl Tuberk Bolezn Legk; 2007; (4):21-5. PubMed ID: 17657963 [TBL] [Abstract][Full Text] [Related]
13. [Antioxidants--effective pathogenetic agents in the combined therapy of pulmonary tuberculosis]. Gur'eva IG; Starostenko EV; Narovlianskaia SE Ter Arkh; 1987; 59(7):72-4. PubMed ID: 3672365 [TBL] [Abstract][Full Text] [Related]
14. [Mumie as a pathogenetic agent in the treatment of tuberculosis]. Agzamov RA; Arifkhanova SI; Vakhidova GA Probl Tuberk; 1988; (7):49-52. PubMed ID: 3265209 [No Abstract] [Full Text] [Related]
15. [The current standard therapy of tuberculosis]. Zierski M Dtsch Med Wochenschr; 1987 Dec; 112(50):1950-5. PubMed ID: 3319477 [No Abstract] [Full Text] [Related]
16. [Current trends in the chemotherapy of tuberculosis]. Zierski M Pneumonol Pol; 1987 Jun; 55(6):236-40. PubMed ID: 3684725 [No Abstract] [Full Text] [Related]